MG-K10 not checked

Shanghai Mabgeek Biotech.Co.Ltd

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
10 active
14 in total · 1 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“loading dose (SC) at Week 0, followed by a single dose Q2W through Week 52”In the company’s words, NCT07540442 on ClinicalTrials.gov
Tested for
Atopic Dermatitis (3 trials), Prurigo Nodularis, Dermatitis, Atopic, Asthma, Chronic Rhinosinusitis With Nasal Polyps, Chronic Spontaneous Urticaria (CSU), Atopic Eczema, Seasonal Allergic Rhinitis and 1 more
Main trialPhase 3
“A phase III clinical study to evaluate the efficacy and safety of a humanized MG-K10 mab injection in subjects with prurigo nodularis.administered every 4 weeks for 56 weeks.”In the company’s words, NCT06779136 on ClinicalTrials.gov

Other drugs for Atopic Dermatitis

All 90 drugs for Atopic Dermatitis

Coming up7

Changes1

Last 90 days

Trials14

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Aug 2026 Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis
Phase 3Not yet recruiting 5 Jan 2027 A Phase III Study of MG-K10 in Adolescents With Moderate-to-Severe Atopic Dermatitis
Phase 3Recruiting 15 Nov 2027 Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma
Phase 3Not yet recruiting 21 Dec 2027 A Study to Evaluate the Efficacy and Safety of MG-K10 in Adults With Chronic Rhinosinusitis With Nasal Polyps
Phase 3Not yet recruiting 31 Mar 2028 A Study of MG-K10 in Chronic Spontaneous Urticaria
Phase 3Not yet recruiting Jan 2029 A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis
Phase 2/3Recruiting 31 May 2025 Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis
Phase 2Not yet recruiting 7 May 2027 A Phase 2 Study of MG-K10 in Chronic Spontaneous Urticaria
Phase 1/2Recruiting May 2025 IB/IIa Study of MG-K10 in Adolescent Moderately Severe Patients
Phase 1/2Not yet recruiting Dec 2027 MG-K10 in Pediatric Atopic Dermatitis (6-12 Years)
Phase 3Unknown 11 Jun 2025 Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis
Phase 2Unknown 22 Sep 2023 A Study of MG-K10 in Subjects With Atopic Dermatitis
Phase 2Completed 9 Mar 2026 A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis
Phase 1/2Unknown 20 Dec 2023 A Study of MG-K10 in Subjects With Asthma
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow MG-K10

Following is part of Solo: you see every change to MG-K10 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in